Alps Pharmaceutical Industrial Co., Ltd.May 26, 2023

FDA 483 - Alps Pharmaceutical Industrial Co., Ltd. - May 26, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Alps Pharmaceutical Industrial Co., Ltd.

Record Details

An FDA inspection of Alps Pharmaceutical Industrial Co. Ltd. in Hida, Gifu, Japan, an Active Pharmaceutical Ingredient (API) Manufacturer, revealed significant deficiencies. The firm failed to validate its cGMP-related software system, lacked controls for authentic personnel signatures on cGMP documents, and did not verify analytical methods for finished product testing after instrument changes.

Company: Alps Pharmaceutical Industrial Co., Ltd.
Inspection Date: May 26, 2023
Product Type: Drugs
Office: Center for Drug Evaluation and Research
Person: Saundrea A. Munroe (Drug Specialist / Drug Investigator)

Open in Dashboard

ID · 1b59829d-c79f-4e56-afa9-dfea63eb6153